Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment.
Anthony McDowellKristen S HillJ Robert McCorkleJustin GorskiAmeen A SalahudeenFrederick Rand UelandJill M KolesarJill M KolesarPublished in: Diagnostics (Basel, Switzerland) (2021)
Artesunate has preclinical activity in ovarian cancer that merits further investigation to treat ovarian cancer.